Liver Metastases are Associated with a Short Post-Progression Survival in a Real-World Group of Patients with Melanoma Treated with Checkpoint Inhibitors
Our results confirm the efficacy of IT in a real-world setting. The altered dynamics of metastases supports studies suggesting a unique role of immune privilege in the liver tissue microenvironment that increases resistance to immunotherapy.
Authors
- Evelyn Gaffal (ORCID: https://orcid.org/0000-0002-4639-9841)
- Miriam Mengoni (ORCID: https://orcid.org/0000-0002-1651-7114)
- Andreas Braun (ORCID: https://orcid.org/0000-0002-6954-0633)
- Thomas Tüting (ORCID: https://orcid.org/0000-0001-7146-0934)
Institutions
- University Hospital Magdeburg (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Oncology and Therapy
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1007/s40487-024-00320-4
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Arbeitsgemeinschaft Dermatologische Forschung